VYTERIS
Vyteris is the maker of the first active drug delivery patch to receive market approval from the U.S. Food and Drug Administration (FDA). Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company (BD), to develop, manufacture, and commercialize pharmaceutical products based upon this unique, advanced drug delivery technology. BD created Transdermal Systems just prior to 1990 and invested 10 years and close to $80 million in developing the basis of the Vyteris transdermal drug delivery system.
VYTERIS
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1990-01-01
Address:
Fair Lawn, New Jersey, United States
Country:
United States
Website Url:
http://www.vyteris.com
Total Employee:
1+
Status:
Closed
Contact:
201-703-2299
Email Addresses:
[email protected]
Total Funding:
1.14 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta LetsEncrypt Amazon PHP Apache 2.4 AdBlock Acceptable Ads Debian Apache 2.2 Shockwave Flash Embed
Similar Organizations
B. Braun Medical
B. Braun Medical is a medical device manufacturing company that specializes in infusion therapy and pain management.
Protherics
Protherics is a biopharmaceutical company that manufactures DigiFab used for overdose treatment & other hospital products for critical care.
Vanrx Pharmasystems
Vanrx Pharmasystems manufactures aseptic filling machines that improve the production of sterile injectables.
Official Site Inspections
http://www.vyteris.com
- Host name: 199.59.243.228
- IP address: 199.59.243.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vyteris"
Vyteris - Crunchbase Company Profile & Funding
Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin using low-level electrical energy. Vyteris is the maker of the first active drug delivery patch to …See details»
Vyteris - Company Profile - Tracxn
Oct 18, 2024 · Vyteris, formerly known as Vyteris Holdings is the maker of the first active, ready-to-use drug delivery patch (LidoSite) to receive marketing clearance from the U.S. FDA. The …See details»
Vyteris - Overview, News & Similar companies | ZoomInfo.com
Vyteris contact info: Phone number: (201) 703-2299 Website: www.vyteris.com What does Vyteris do? Vyteris, Inc. is a specialty pharmaceutical company developing and commercializing …See details»
Vyteris Inc - Company Profile and News - Bloomberg Markets
Vyteris, Inc. develops and manufactures pharmaceutical products based upon its drug delivery technology. The Company's transdermal drug delivery technology delivers drugs through the …See details»
Vyteris - Products, Competitors, Financials, Employees, …
Vyteris is a Healthcare/Medical Devices & Equipment company based in Fair Lawn, New Jersey. Use the CB Insights Platform to explore Vyteris's full profile.See details»
Vyteris to be transformed into a contract research organisation
May 20, 2011 · Vyteris, a US developer of the first FDA-approved active transdermal patch that delivers drugs through the skin, has decided to transform the firm into a diversified, specialist …See details»
Vyteris - Funding, Financials, Valuation & Investors - Crunchbase
Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin using low-level electrical energy.See details»
Vyteris - Crunchbase
Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin using low-level electrical energy.See details»
Vyteris - LinkedIn
Vyteris | 117 followers on LinkedIn. ... PRISM Vision Group Hospitals and Health Care New Providence, New JerseySee details»
Lidocaine Transdermal — Vyteris | Drugs in R&D - Springer
Nov 27, 2012 · Vyteris Inc. (formerly known as Drug Delivery Technologies, Inc.) is developing an advanced lidocaine delivery system for rapid dermal anaesthesia. 1 Lidocaine is delivered via …See details»
Vyteris - insights.citeline.com
Mar 12, 2001 · New drug application submission for the firm's lidocaine-based iontophoresis transdermal drug delivery system is anticipated by year-end, the firm says. Privately held …See details»
Lidocaine/epinephrine transdermal - Vyteris - AdisInsight - Springer
Jun 27, 2019 · Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Vyteris Inc. (formerly known as Drug Delivery Technologies, …See details»
Vyteris Closes Merger with MediSync BioServices - Business Wire
Apr 18, 2011 · Vyteris, Inc. is the maker of the first active, ready-to-use drug delivery patch (LidoSite®) to receive marketing clearance from the U.S. Food and Drug Administration (FDA). …See details»
Vyteris, Georgia Tech to develop transdermal drug delivery
Aug 25, 2010 · Vyteris, a New Jersey-based company that bills itself as "a leader in alternative drug delivery technology," makes drug-delivery patches. Mark Prausnitz, a Georgia Tech …See details»
Vyteris - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin using low-level electrical energy.See details»
Vyteris Announces Redirection of Business towards the …
Feb 6, 2008 · Vyteris, with approval from its Board of Directors, has redirected its business to focus on the development of peptide delivery using its Smart Patch technology.See details»
C&L: McIntyre named Vyteris CEO - Fierce Biotech
Dec 20, 2005 · Timothy J. McIntyre was named Vyteris's CEO and member of the board of directors. Mr. McIntyre succeeds Vincent De Caprio, Ph.D. who will step down as CEO and …See details»
Vyteris Announces First Successful Non-Invasive Delivery of …
Jan 23, 2008 · Vyteris, Inc. and Ferring Pharmaceuticals have announced results from a completed Phase 1 clinical trial demonstrating that Vyteris’ patented Smart Patch transdermal …See details»
The LidoSite TM iontophoretic system for topical delivery of …
Vyteris (Fair Lawn, NJ) now commercializes a recently FDA approved, disposable pre-filled electrode system that is used with a reusable power supply (Figure 4). Recently, the specific …See details»